Skip to main content
Clinical Trials/CTRI/2020/02/023125
CTRI/2020/02/023125
Not yet recruiting
Phase 4

Efficacy, Safety and Acceptability of Intravenous Versus Oral Iron Therapy in Postpartum Anemia - A Randomised Controlled Trial

Department of Obstetrics And Gynecology0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Obstetrics And Gynecology
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Obstetrics And Gynecology

Eligibility Criteria

Inclusion Criteria

  • Patients with Hemoglobin between 8\-10gm/dl, 36\-48 hours after delivery.
  • Group A will be treated with Intravenous Iron .
  • Group B will be treated with Tablet Iron.

Exclusion Criteria

  • Peripartum Blood Transfusion
  • Intolerance To Iron Derivatives
  • Clotting disorders
  • Patients with Anemia other than that caused by blood loss secondary to delivery and iron deficiency anemia.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency Anemia
EUCTR2019-003821-70-PLAmerican Regent, Inc.10
Active, not recruiting
Phase 1
Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled studyModerate-to-severe COVID-19 pneumoniaMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-003614-13-ITImmuneMed Inc.105
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients
IRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
Active, not recruiting
Not Applicable
intravenous immunoglobulin for the treatment of infections in patients with post solid organ transplantation hypogammaglobulinemiainfections in patients with post solid organ transplantation IgG hypogammaglobulinemiaMedDRA version: 15.0Level: LLTClassification code 10054427Term: HypogammaglobulinemiaSystem Organ Class: 10021428 - Immune system disordersTherapeutic area: Body processes [G] - Immune system processes [G12]
EUCTR2012-001327-12-ESFundacion para la Investigación Biomédica del Hospital Gregorio Marañón
Not yet recruiting
Phase 4
Comparing Tramadol vs Paracetamol for Pain Relief in Acute Pancreatitis: A Randomized Controlled Trial
CTRI/2024/06/068751DR ABHIJEET SHRIDHAR